Dolors Puigdemont, MD, PhD, is affiliated with the Department of Psychiatry at Hospital de la Santa Creu i Sant Pau and Institut d’Investigació Biomèdica Sant Pau (IIB SANT PAU), the Department of Psychiatry and Legal Medicine at Universitat Autònoma de Barcelona (UAB), and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) in Madrid, Spain. Puigdemont has published research on treatment-resistant depression, including long-term outcomes of deep brain stimulation, the effects of pindolol on selective serotonin reuptake inhibitor antidepressant response in nonresistant depression, and the use of ziprasidone in borderline personality disorder. The author’s work, spanning from 2008 to 2023, frequently involves collaboration with Enric Alvarez, Javier de Diego-Adeliño, María J. Portella, Víctor Pérez, and Ana Martín-Blanco.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
